Incannex Announces Initiation of Research Coverage by Alliance Global Partners

$IXHLPress releaseJun 9, 2026, 8:00 AM ETRead the release

Alliance Global Partners initiated coverage of Incannex Healthcare with a BUY rating and a US$18.00 price target. The report highlights the company’s lead programs IHL-42X for obstructive sleep apnoea and PSX-001 for generalized anxiety disorder.

Key figures

Price target: 18
Analyst rating: BUY

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $40.67/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.